Spirea


Programme

Accelerate alumni

Sector

Healthcare/Pharma/Biotech



Logo spirea
Programme
Accelerate Alumni (Cohort 4)
Founded in
2017
Total funds raised
£2.9 million
Employees
1-10
Industry
Healthcare, pharma, biotech

Spirea, a spinout from the University of Cambridge, is developing the next generation of antibody drug conjugate cancer therapeutics which carry more drug payload to tumour cells resulting in greater efficacy and tolerability and the ability to treat more cancer patients.

News about Spirea

Ventures mentored at the Accelerate Cambridge programme are tackling the disease from various angles.

Ventures mentored at the Accelerate Cambridge programme are tackling the disease from various angles.

21toWatch Entrepreneurship Centre winners2023.

Seven ventures or people with ties to the Entrepreneurship Centre at Cambridge Judge Business School are named in the #21toWatch list of science and tech talent in and around Cambridge.

Biotech 883 x 432

Dr Rebecca Myers of the Entrepreneurship Centre at Cambridge Judge is included in the Movers and Shakers in BioBusiness 2020 report by the BioBeat project.

Top